Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jun 17;10(6):967. doi: 10.3390/vaccines10060967

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Anti-SARS-CoV-2 spike1 IgG titer was significantly upregulated after the first booster. Anti-SARS-CoV-2 spike protein IgG antibody titer in hemodialysis patients and controls before and 2–3 weeks after the first booster. (a) In red: patients and volunteers infected with SARS-CoV-2 after the booster dose during the 280-day study follow-up. (b) Changes in antibody titers in each participant. All dialysis patients but one showed upregulation of anti-S1 antibodies. * p < 0.05; **** p < 0.0001.